Friday, March 7, 2008

Post a comment on the Vitamin Information Center's article - "Vitamins Found No Help for Down's Syndrome"

An article on the antioxidant & folinic acid study came through the Google Alerts. It's an article on the Vitamin Information Center website. The title of the article is Vitamins Found No Help for Down's Syndrome. I posted a slightly edited version of my letter to the Washington Post editor. You can see the article from the Vitamin Information Center at the link below.

http://tinyurl.com/2cp5lm

Post a comment to it, so that more accurate information on TNI can be seen there!

Sufficient Amounts of Antioxidants

I posted the response to the antioxidant & folinic acid study from Dr. Hickey on the DSTNI yahoo group.

Richard asked, "Do you know if NVD contains the amounts of antioxidants Dr. Hickey deems necessary?"

I thought that was a great point, so I looked it up and here's what I found:

For Vitamin C, Dr. Hickey says, "Assuming a weight of 8 kg for a 7 month old child, a minimal therapeutic ascorbate dose of 140 mg/kg gives 1120 mg, i.e. approximately one gram."

In Nutrivene-D the Vitamin C dosage for a 7 month old who weighs 9kgs or less is 200mgs.

For Vitamin E, Dr. Hickey says, "Assuming 40 IU per kg, a minimum dose of about 320 IU of a high quality, natural form of vitamin E would be required for a 7-month-old child."

In Nutrivene-D for a 7 month old child, weighing 9kgs or less, they would get 80 IU.

So, the one is lower than what Dr. Hickey may deem necessary, but the other is higher than his minimum dose.

Thursday, March 6, 2008

News article, "Supplements Don't Help Down Babies" & letter to editor

This news story came through the Google Alerts the other day and I just couldn't stand it anymore. I've seen plenty of these news headlines proclaiming that supplements are no good for people with DS.

So I wrote a letter to the Washington Post editor about this news article. Below is the article and the letter to the editor.

~ Qadoshyah

Supplements Don't Help Down Babies

Tuesday, March 4, 2008; HE02

Giving babies with Down syndrome supplements containing folate and other vitamins does nothing to improve their development, British researchers reported last week. The finding, published in the journal BMJ, may dampen parental enthusiasm for vitamin supplementation, which is widespread among families with a mentally retarded child.

To test a hypothesis suggested by previous studies, researchers at Peninsula Medical School in Exeter randomly assigned 156 babies younger than 7 months who had been born with Down syndrome to one of four groups. The first received daily supplements containing folic acid, another got antioxidants including Vitamin E, a third group received both and a fourth was given a placebo.

Compliance with the regimen was verified by blood tests, and neither parents nor researchers were told which substance the babies had received until the trial ended.

After 18 months, researchers assessed the cognitive and physical development of the infants. They found that supplementation had no effect on the achievement of developmental milestones, such as the ability to sit or stand unassisted, or on the number of words a baby understood or said.

"Parents who choose to give supplements to their children need to weigh their hope of unproven benefits against potential adverse effects from high-dose, prolonged supplementation," the researchers said.

-- Sandra G. Boodman
(http://www.washingtonpost.com/wp-dyn/content/article/2008/02/29/AR2008022903404.html).

~~~~~~~~~~~~~~~~~~

Dear Editor,

I read the article, Supplements Don't Help Down Babies, by Sandra Boodman.

I wanted to write and share some more information about the study which Sandra wrote about. The study's name is, Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

The study claims that supplementation with antioxidants and folinic acid showed no benefit to children with Down syndrome. But, the study does not use appropriate dosing levels of antioxidants and therefore cannot truly see what benefit supplementation has on children with Down syndrome.

The study used very low doses of antioxidants in these children. Oxidative stress is known to be a large part of Down syndrome. In order for antioxidant supplementation to really help the individual with Down syndrome, much higher doses of supplements need to be given.

I am not promoting "mega-vitamin therapy," that is history. People just need to realize that higher doses (not mega doses though) of supplements need to be given to see much of any benefit.

It also should be noted that if someone reads the full text of the study, there were some differences between the children who took the supplements and the placebo group. The differences were not "statistically significant" so they are not reported in the abstract of the study or in the media.

Something else that needs to be acknowledged is the use of the RDA for people with Down syndrome. The RDA is for "generally all healthy people." This may not include people with a genetic abnormality which may make their metabolism and biochemical needs different than the general population. Sure, the RDA may be a good guideline, but it cannot be used as the standard for people with Down syndrome. The researchers did note this in their study. They say that the doses that were given to the children "may have been inadequate to affect biochemical pathways."

My 3 year old brother has Down syndrome. We give him Nutrivene-D Advanced Daily Antioxidant Supplement. It has proven to be extremely beneficial and helpful to him. It has changed his life dramatically. If it had not been for us starting him on Nutrivene-D at 8 months of age, he would not be as healthy and thriving as he is today.

I hope that people will not just believe all the news headlines that say all kinds of things ranging from "Supplements Don't Help Down Babies," to "Antioxidants don't help Down syndrome," or even "Supplements for Down's children 'Waste of cash'."

~ Qadoshyah Fish

Response to the folinic acid & supplement study - Were sufficient antioxidants employed in this study?

I just happened to look at some of the responses to the recent study on folinic acid & antioxidants in DS. I thought this response was a great response! He (Steve Hickey, PhD) explains how the study used such low doses of these nutrients that it could not benefit the children like they need to.

I also liked the last statement of his response. He says,

"Moreover, the unfortunately common propensity to give insufficient and inappropriate nutrients in trials is potentially harmful. Reports based on low intakes may prevent subjects with Down's and others from gaining benefits which are obscured by these unsuitable studies."

~ Qadoshyah

http://www.bmj.com/cgi/eletters/bmj.39465.544028.AEv2#191091

Were sufficient antioxidants employed in this study?

Steve Hickey PhD,
Lecturer
FCET, Staffordshire University, England, ST16 9DG,
Hilary Roberts PhD, Andrew Hickey



The paper by Ellis et al. illustrates a widespread problem in medicine: failure to understand the actions of antioxidants in disease. The study provides little evidence on the question of whether subjects with Down's might benefit from dietary antioxidants, because, as the authors themselves suggest, the low doses of supplements "may have been inadequate to affect biochemical pathways".

The disease mechanism for Down's syndrome arises from an increase in the activity of redox active enzymes. This leads to excess hydrogen peroxide, which causes oxidation and free radical damage in the brain. By definition, antioxidants can prevent such damage, thus potentially forming an appropriate treatment. The crucial research question is whether the appropriate dietary antioxidants can be given safely in doses sufficient to influence the pathology of the disease.

In order to influence brain pathology, dietary substances must enter the brain in sufficient concentration to act as antioxidants. The levels of primary antioxidants (vitamins C and E) used in this study were similar in magnitude to the corresponding recommended dietary allowance (RDA) levels. The subjects were young children, who would normally require lower doses than adults. However, it is important to remember that the antioxidants were intended to treat disease and, hence, we are in the realms of pharmacology rather than nutrition.

Claims for vitamin C as an antioxidant therapy involve very high doses. According to popular belief, one gram is a high dose. Contrary to this, prevention of colds (80-90%) requires doses of 10g per day or above; treatment calls for doses an order of magnitude larger. So, for example, claims for treating a cold effectively (Klenner, Cathcart, and others) [1] involve doses in the range 30g-150g per day.[2] Below these intakes, clinical effects are smaller and are more variable.[3]

The 50mg daily doses of vitamin C used in this study are substantially below pharmacological levels. Assuming a weight of 8 kg for a 7 month old child, a minimal therapeutic ascorbate dose of 140 mg/kg gives 1120 mg, i.e. approximately one gram. Thus, the dose of ascorbate employed in this study was approximately 1/20th of the minimum required. Similar considerations apply to the other nutrients. The short half-life of vitamin C means dosing frequency is also important (6 hourly or less)[2].

Subjects took 100mg of "vitamin E"; the form was not specified, although blood á-tocopherol levels were measured. Vitamin E is not a single molecule, but a range of substances that can prevent lipid oxidation in vivo. Numerous different molecules show vitamin E activity, particularly the tocopherols and tocotrienols; each has a specific pharmacology and distribution in the body. Synthetic forms, such as dl- alpha-tocopherol, are often used in studies, though they are far less effective than the naturally occurring forms.

To act as an antioxidant, vitamin E is required in higher intakes than previously realised.[4] Indeed, Balz Frei, of the Linus Pauling Institute, has described almost all clinical trials of vitamin E as "fatally flawed" because they used an insufficient dose of vitamin E.[5] To act as an antioxidant in vivo, an adult requires between 1600 and 3200 IU. Assuming 40 IU per kg, a minimum dose of about 320 IU of a high quality, natural form of vitamin E would be required for a 7-month-old child. The 100mg (synthetic?) dose employed may not act as an effective antioxidant in the brain, particularly in the absence of high levels of vitamin C.

The study employed folinic acid (0.1mg), selenium (10 ìg), zinc (5 mg), and vitamin A (0.9 mg) at low doses. Ellis et al. note that the response to folate may be enhanced by adding selected nutrients (methionine, methyl B-12, thymidine, and dimethylglycine). The specific forms of the nutrients employed was not made clear, for example forms of selenium, such as sodium selenite and methylselenocysteine, differ in pharmacology and antioxidant properties. Although we use vitamins C and E to address the main research problems, the selection and dosage of all nutrients in this study was suboptimal.

Biochemical measures in the study suggest that supplementation did not affect oxidative stress levels; this supports our suggestion that the doses employed were too low to act as in vivo antioxidants in these subjects.

The pathology of Down's syndrome has a specific oxidative mechanism. The laws of physical chemistry suggest there is little point carrying out studies using doses of antioxidants that are too low to provide the intended action: prevention of oxidation in the brain. It is possible to select suitable dietary antioxidants that can enter the brain and provide them in sufficient doses to have the desired biophysical effect.

This study did not address the role of antioxidants in Down's, as it did not use sufficient nutrients to act in vivo. Moreover, the unfortunately common propensity to give insufficient and inappropriate nutrients in trials is potentially harmful. Reports based on low intakes may prevent subjects with Down's and others from gaining benefits which are obscured by these unsuitable studies.

[1] Cathcart R.F (1985) Vitamin C, the nontoxic, nonrate-limited antioxidant free radical scavenger, Medical Hypothesis, 18, 61-77.

[2] Hickey S. Roberts H. (2004) Ascorbate: The Science of Vitamin C, Lulu press.

[3] Cathcart R.F. (1981) Vitamin C, Titration to Bowel Tolerance, Anascorbemia, and Acute Induced Scurvy, Medical Hypothesis, 7, 1359-1376.

[4] Roberts L.J. Oates J.A. Linton M.F. Fazio S. Meador B.P. Gross M.D. Shyr Y. Morrow J.D. (2007) The relationship between dose of vitamin E and suppression of oxidative stress in humans, 1388-1393.

[5]Frei B. (2007) in Vitamin E Trials 'Fatally Flawed', ScienceDaily, Sep. 26.

One more response by Miriam

Here's one last response by Miriam (from Einstein-Syndrome) to the folinic acid & antioxidant study ~ Long term negative outcomes of vitamin therapy.

Sunday, March 2, 2008

John Marrs!

Jenn Marrs' son, John, has been called "The Wonder Boy" on DS listservs and in the Circle of Friends II book.

Jenny has done a lot with John to exceed what they were told John would, or more like it, would not do. John's new website is http://mysite.verizon.net/ress9jo2/johnmarrs . Jenny has a lot of very helpful and resourceful information on that site. I remember reading her program that she did with John quite a bit when my brother was younger.

Jenny is contributing several articles to our book ;). Thanks Jenny!

More response to the folinic acid & antioxidant study

Miriam (from Einstein-Syndrome) has written part 2 & 3 of her response to the recent study on supplements in DS. Here are the links to that:

Part 2: http://einsteinsyndrome.wordpress.com/2008/03/01/just-a-waste-of-cash-part-2/

Part 3: http://einsteinsyndrome.wordpress.com/2008/03/02/just-a-waste-of-cash-part-3/

Wednesday, February 27, 2008

Response to the study on Antioxidants in Down syndrome

Miriam, from the Einstein Syndrome site, posted part of her response to the recent study on Antioxidants in Down Syndrome.

It's a very informative article and can be found here, Just a waste of cash!

Monday, February 25, 2008

Coenzyme Q10 Supplemenation . . . beneficial

I happened to be run across this article today and I thought it was pretty interesting.

Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21.

Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati Medical Center, Cincinnati, OH 45229-3039, USA. michael.miles@cchmc.org

Endogenous coenzyme Q10 is an essential cofactor in the mitochondrial respiratory chain, a potent antioxidant, and a potential biomarker for systemic oxidative status. Evidence of oxidative stress was reported in individuals with trisomy 21. In this study, 14 children with trisomy 21 had significantly increased plasma ubiquinone-10 (the oxidized component of coenzyme Q10) compared with 12 age- and sex-matched healthy children (historical controls). Also, the mean ratio of ubiquinol-10 (the biochemically reduced component):total coenzyme Q10 was significantly decreased. After 3 months of ubiquinol-10 supplementation (10 mg/kg/day) to 10 patients with trisomy 21, the mean ubiquinol-10:total coenzyme Q10 ratio increased significantly above baseline values, and 80% of individual ratios were within normal range. No significant or unexpected adverse effects were reported by participants. To our knowledge, this is the first study to indicate that the pro-oxidant state in plasma of children with trisomy 21, as assessed by ubiquinol-10:total coenzyme Q10 ratio, may be normalized with ubiquinol-10 supplementation. Further studies are needed to determine whether correction of this oxidant imbalance improves clinical outcomes of children with trisomy 21.

PMID: 18021919 [PubMed - indexed for MEDLINE]

Friday, February 22, 2008

Medical News: Vitamins Found No Help for Down's Syndrome Children

This is a new study that just came out. The full text can be seen at:
http://www.bmj.com/cgi/reprint/bmj.39465.544028.AEv2.pdf.

Of course, this doesn't change a thing with us! I know that giving my brother supplements has helped him tremendously!

I read the full text of the article and noted a couple interesting things.

The first quote here, they admit that they used low doses. They used some very low doses (5mgs of zinc, 10mcg of selenium, etc). I know, from experience especially, that higher doses of these nutrients are needed to see a benefit. I wonder if they checked the blood levels of zinc in these children? It didn't mention it in the full text. The only nutrient level tested, that was mentioned, was Vitamin E.

Also, in this first quote they admit that their low doses may not have been good enough to combat the biochemical issues in DS!

"One limitation of our study was the relatively low dose of supplements compared with commercially available preparations (Nutrivene-D and Euro TNI), which may have been inadequate to affect biochemical pathways."

I thought this was good too . . . In this second quote they admit that longer duration of supplementation may see effects.

"Our results do not exclude the possibility that subtle effects of supplementation on development might be detectable given longer term supplementation and follow-up."

Another thing I noticed is that they used RDA doses also, which is something that cannot necessarily be followed for those with DS. The reason being because the RDA is for "generally all healthy people," and therefore excludes those with something such as a genetic abnormality.

http://www.medpagetoday.com/Pediatrics/GeneralPediatrics/tb/8468


Vitamins Found No Help for Down's Syndrome Children

EXETER, England, Feb. 22 -- Children with Down's syndrome did not improve their development with the use of antioxidant vitamins, researchers here found.
Action Points
--------------------------------------------------------------------------------

a.. Explain to interested patients that early vitamin supplementation for children with Down's syndrome may not improve development.


b.. Note that antioxidant supplements and folinic acid cannot be recommended for children with Down's syndrome based on the available evidence.
Psychomotor and language development scores were no better among British children with Down's given antioxidants or folinic acid (an active metabolite of folic acid) or both than among those who received neither, reported Stuart Logan, MBChB, of Peninsula Medical School, and colleagues online in BMJ.

Nor were biochemical measures of oxidative stress improved by the supplements in the randomized controlled trial.

Vitamin and mineral supplements marketed as holding substantial benefits for children with Down's are commonly used in the United States and Europe.

However, "parents who choose to give supplements to their children need to weigh their hope of unproved benefits against potential adverse effects from high dose, prolonged supplementation," the researchers wrote.

The lack of benefit from postnatal supplementation may not be surprising because Down's screening identifies differences between fetuses with and without trisomy 21 as early as 10 weeks' gestation, commented Tim Reynolds, M.D., of Queen's Hospital in Burton-on-Trent, England, in an accompanying editorial.

"Until evidence of any benefit of expensive vitamin supplements is available, they cannot be recommended," he said.

Developmental delay in Down's has been thought to result from oxidative neuronal damage, abnormal folate metabolism, or both, they said. The evidence, though, for nutritional interventions to counteract these effects has been poor, particularly in younger children, who had been thought to be most likely to benefit.

So the researchers undertook a well-designed study among 156 infants younger than seven months with Down's but no severe cardiac defects or other serious long-term illness.

They randomized the children to a daily oral dose of antioxidants (selenium 10 μg, zinc 5 mg, vitamin A 0.9 mg, vitamin E 100 mg, and vitamin C 50 mg) or folinic acid (0.1 mg) or both, or placebo.

All were given as a powder to be mixed with food or drink and were increased in dose by 30% after a child's first birthday.

After 18 months of follow-up, overall developmental scores as measured on the Griffiths mental developmental scales were similar between children given antioxidants and those who were not (mean 57.3 versus 56.1; adjusted mean difference 1.2 points, 95% confidence interval −2.2 to 4.6).

Likewise, developmental scores were similar for children randomized to folinic acid supplements or not (mean 57.6 versus 55.9; adjusted mean difference 1.7, 95% CI −1.7 to 5.1).

For language development after 18 months of follow-up, the number of words said or signed was similar for children given antioxidants versus none (ratio of means 0.85, 95% CI 0.6 to 1.2) and for those given folinic acid versus none (ratio of means 1.24, 95% CI 0.87 to 1.77).

Nor was there any difference in the age at which infants reached milestones in motor development.

Age at sitting without support was not significantly improved with antioxidants (hazard ratio 1.10, 95% confidence interval 0.77 to 1.56) or folinic acid (HR 1.25, 95% CI 0.88 to 1.78).

Standing did not start significantly earlier with antioxidants (HR 1.25, 95% CI 0.88 to 1.78) or folinic acid (HR 1.14, 95% CI 0.76 to 1.71).

To see whether the supplements could be having a subclinical effect, the researchers looked at biomarkers of oxidative stress in blood samples obtained blood at age one and urine samples.

Activity of antioxidant enzymes -- red cell superoxide dismutase and red cell glutathione peroxidase -- was not detectably different between treatment groups. Urinary isoprostane concentrations, a marker of lipid perioxidation, were also similar across groups, "indicating that supplementation did not affect oxidative stress."

The only short-term side effect in the study was an increase in vomiting among infants taking antioxidants (P=0.002), "but the side effects of higher dose preparations used over a long period are unknown."

Doses used in the study were at least 100% of the recommended daily allowance for all the vitamins and folinic acid, but still were relatively low compared with commercially available preparations, they noted.

"We were reluctant to use higher doses, as data on the safety of high doses for young children are lacking and high dose vitamin C may in fact exhibit pro-oxidant properties," Dr. Logan and colleagues wrote.

Related Posts with Thumbnails